VRG Therapeutics
PrivateLast Round
Series B
Feb 20, 2024
Total Funding Raised
$11M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
VRG Therapeutics operates in Healthcare & Life Sciences and is based in Budapest. Its latest recorded funding round was a Series A round in August 2023.
VRG Therapeutics is a biotechnology company that develops miniprotein-based therapeutics and cell and gene therapy products using its proprietary AI-driven drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VRG Therapeutics Comparables
Compare VRG Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AI Proteins | 86% | |
| Generate Biomedicines | 81% | |
| ProteinQure | 81% |
For institutional investors. Book with your work email.
VRG Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 20, 2024 | ||||
| Series A | Aug 14, 2023 |
For institutional investors. Book with your work email.
VRG Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Szechenyi Funds | Series A |
| National Research, Development and Innovation Office (NKFIH) | Grant |
| Vascular Group | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 7, representing 21% of headcount.
- Apr 18, 2026
Monthly visitors grew 208% MoM, reaching 2.2K.
For institutional investors. Book with your work email.
VRG Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VRG Therapeutics's valuation, stock price, and market status.
Is VRG Therapeutics a public or private company?
VRG Therapeutics is a private company.
What is the current stock price of VRG Therapeutics?
VRG Therapeutics is a private company, so its shares have no public market price. Caplight tracks VRG Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VRG Therapeutics worth (valuation)?
Valuation information for VRG Therapeutics is not publicly available.
Can I buy VRG Therapeutics stock?
VRG Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VRG Therapeutics's last funding round?
VRG Therapeutics's most recent funding round was Series B on February 20, 2024.
Who are the main investors in VRG Therapeutics?
Key investors in VRG Therapeutics include Szechenyi Funds.
Will VRG Therapeutics IPO soon?
No public IPO plans have been announced for VRG Therapeutics.
How can I track VRG Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in VRG Therapeutics's shares on secondary markets.